Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michelle L. Basil currently holds 68,829 shares of HAEMONETICS CORP (HAE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michelle L. Basil has been a net seller of HAE stock. They have purchased $0 and sold $11.6M worth of shares.
Michelle L. Basil's most recent insider trade was on May 15, 2026, when they sold 28,424 shares at $0.00 per share.
Michelle L. Basil serves as Executive at HAEMONETICS CORP (HAE). They have executed 71 insider transactions totaling $11.6M over their tenure at the company.
Michelle L. Basil holds the position of Executive at HAEMONETICS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Michelle L. Basil has shown a selling trading pattern, with $0 in total purchases and $11.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michelle L. Basil was on Sep 15, 2022, when they sold $2.2M worth of HAE shares. This transaction involved 27,769 shares at $77.76 per share.
Michelle L. Basil currently owns 68,829 shares of HAEMONETICS CORP (HAE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michelle L. Basil's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michelle L. Basil has 71 Form 4 filings on record as an insider at HAEMONETICS CORP.
Set alerts for Michelle L. Basil and 40,000+ other insiders.